Beximco Pharmaceuticals Limited (BXP)

GDR (EACH REPR 1 ORD BDT10)

Sell: 43.00p|Buy: 45.00p|Change: 1.00 (-2.27%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Open

44.00p

Previous close

44.00p

Trade high

43.00p

Volume

1,250

Year high

52.333p

Year low

28.00p

Dividend yield

5.95%

Market capitalisation

£191.83 mn

P/E ratio

5.07

ISIN

US0885792061

This share can be held in a Dealing account SIPPand can be used with Dividend reinvestment

Share price

Dividends

	Previous	Latest
Record date	13/11/2023	25/11/2024
Ex-dividend date	10/11/2023	22/11/2024
Payment date	08/02/2024	06/02/2025
Amount	$0.03175	$0.03272

Performance 15/10/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann

	Total return (%)
Beximco Pharmaceuticals Limited	0.00
More...

Company profile

Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from domestic sales.

Sector

Healthcare

News

Recent trades

Date	Time	Price	Quantity	Value (£)
16/10/2025	10:05:25	43	1,250	537.50
14/10/2025	03:27:44	43.9	2,268	995.65
10/10/2025	12:42:23	43.96	3,000	1,318.80
10/10/2025	08:14:21	43.4	2,000	868.00
10/10/2025	08:14:21	43.4	2,000	868.00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.